European Respiratory Society

Genome-wide expression profiling of T-cells in childhood wheeze

A. Bosco, P. G. Holt

Elucidation of the molecular mechanisms underlying asthma and related phenotypes is a monumental task. To date, >100 susceptibility genes have already been identified with diverse functions. These can broadly be classified into those involved in the regulation of the innate and adaptive immune system, epithelial biology, lung function and remodelling, and disease severity 1. An important advance that has the potential to accelerate progress in this area is the emergence of microarray-based expression profiling technology that enables the systematic, genome-wide analysis of the transcriptional changes underlying cellular behaviour and functionality. This new technology has already revealed important insights into asthma pathogenesis in experimental animal models 2, 3 but has yet to be exploited to a significant degree in the context of human asthma. In the current issue of the European Respiratory Journal, the study by Kapitein et al. 4 focuses on CD4 T-cell phenotypes associated with childhood wheeze, which represents a significant initial step in this direction.

CD4 T-cells, especially T-helper (Th)2-polarised effectors, are acknowledged to be major players in the pathogenesis of human asthma 1. Previous studies have demonstrated that Th2 cytokine production is elevated in airway CD4 T-cells in both atopic and nonatopic forms of the disease 5, 6. Moreover, levels of expression of Th2 cytokines by airway CD4 T-cells correlate with disease severity 7. Findings in blood, whilst not always reproducing those in the airways 7, 8, have demonstrated that T-cell response patterns are, to some degree, predictive of the later development of wheeze 9. Importantly, heterogeneity in blood T-cell response patterns is associated with variable expression of asthma/wheeze versus bronchial hyperreactivity 10, suggesting that there are covert relationships between asthma-related phenotypes and underlying immunological phenotypes.

A limitation of these earlier studies, imposed by the technology available at the time, was the restricted number of T-cell-associated genes investigated, because it is now recognised that hundreds of genes participate in T-cell responses, including Th2 responses against asthma-associated antigens 11, 12. The study by Kapitein et al. 4 begins the long process towards redressing this deficiency by applying microarray technology in a preliminary investigation of gene expression profiles in blood CD4 T-cells from children with transient and persistent wheeze. The blood samples used were obtained in the absence of current symptoms; therefore, the data should reflect variations in baseline gene expression in T-cells in the absence of active inflammation.

The data from the study by Kapitein et al. 4 demonstrates that there were similarities in the differential gene expression signatures in both transient and persistent wheezers relative to healthy controls, suggesting that similar mechanisms may be operating in these distinct phenotypes. This “common” expression signature includes the highly conserved heat shock proteins (hsp), which are induced in conditions of cellular stress and inflammation and are implicated in T-cell regulation of chronic inflammation 13. Several mechanisms relevant to airways inflammation are likely to be susceptible to control by endogenous hsp. In particular, regulatory T-cell (Treg) function, which can be enhanced via hsp-mediated activation of TLR signalling pathways on Treg 14, and an additional Treg subset that can be triggered directly by self hsp 13. In the common expression signature, the upregulation of natural killer (NK) cell-associated markers was also prominent, of which CD226 has previously been reported to be elevated in NK T-cells from asthma patients 15 and may constitute an innate immune-axis driving disease pathogenesis 16, 17. The Th2 regulators CISH 18 and CD27RA 19 also featured in the common gene signature upregulated in both wheezing phenotypes.

The T-cell profile from transient wheezers was characterised by a reduced expression of genes involved in interferon signalling and oxidate stress (glutathione S-transferase M1; GSTM1). A deficiency of these two pathways has previously been implicated in the susceptibility of the asthmatic epithelium to viral infection 20 and oxidative damage 21. In this context it is noteworthy that transcriptional profiling of lymphocytes can reveal general insights into gene expression, which is also relevant to genes that primarily function in other cell types 22. An additional finding of interest was upregulation of annexin-A1 (also known as lipocortin) in the transient wheezers. Annexin-A1 is an anti-inflammatory protein currently thought to mediate some of the anti-inflammatory activities of corticosteroids on innate immune cells; however, paradoxically, annexin-A1 signalling can enhance T-cell activation pathways 23.

Analysis of gene expression patterns in T-cells isolated from persistent wheezers highlighted a deficiency in expression of the prostaglandin (PG)E2 receptor subtype EP2 (PTGER2). Inhalation of PGE2 prior to allergen challenge in humans in vivo attenuated asthma-related symptoms in the airways 24. PTGER2 signalling may have a dual protective role in asthma, promoting relaxation of airway smooth muscle 25 and enhancing the function of Treg via the induction of FoxP3 26, 27. Finally, several of the genes highlighted in the study by Kapitein et al. 4 (arachidonate 5-lipoxygenase, GSTM1 and PTGER2) harbour polymorphisms relevant to the pathogenesis of asthma and response to therapy 1, 28, suggesting that gene expression profiling studies in lymphocytes may be exploited to select logical candidates for follow-up in genetic studies 22.

The study by Kapitein et al. 4 has several limitations which should be acknowledged when interpreting the overall findings. Gene expression is highly variable in human subjects 29, thus moderate sample sizes are essential in such studies. Therefore, the findings of Kapitein et al. 4, in a relatively small study group, must be replicated in an independent and larger sample. More importantly, the study population was heterogeneous with respect to sex, atopic status, family history of asthma/atopy and use of medications at the time of blood sampling, which may have confounded the analyses. It is also noteworthy that there is limited overlap in the gene lists reported in expression profiling studies of asthma 30. In particular, expression of Th2 signature genes 11, 12 was not a prominent feature in the results of the study by Kapitein et al. 4. However, this may be a methodology issue, as it has been reported that expression of Th2-related genes in resting circulating CD4 T-cells from atopic asthmatic adults is undetectable by microarray but can be readily identified by more sensitive quantitative RT-PCR 31. It is also possible that even if T-cells are major contributors to the airway pathology underlying wheeze, the differences between affected and healthy subjects in relevant expression profiles of circulating T-cells may, nevertheless, only manifest following activation by relevant environmental triggering agents (e.g. allergen or virus). Moreover, there are few studies on which to base an estimate of how long such triggering-induced changes in gene expression may persist in circulating T-cells following a wheezing event. The logical approach to addressing these complexities is to track groups of subjects prospectively. Kapitein et al. 4 have stated that this is their preferred follow-up strategy.

Notwithstanding these limitations, the preliminary study by Kapitein et al. 4 provides the first published evidence that the baseline gene expression programme may be altered in blood CD4 T-cells in wheezers relative to that in healthy controls and, moreover, may vary between different wheezing phenotypes. The microarray technology demonstrated herein has great potential to elucidate this and related issues, employing variations of the utilised study structure. Casting the net wider to include profiling of other effector-cell populations implicated in airways inflammation, in particular CD8 T-cells and monocytes, would represent a logical extension of this promising approach.

Statement of interest

None declared.